Long-term overall survival (OS) with nivolumab in previously treated patients with advanced renal cell carcinoma (aRCC) from phase I and II studies Meeting Abstract
| Authors: | McDermott, D. F.; Motzer, R.; Atkins, M. B.; Plimack, E. R.; Sznol, M.; George, S.; Drake, C. G.; Rini, B. I.; Choueiri, T. K.; Kuzel, T.; Sosman, J. A.; Smith, D. C.; Vaishampayan, U. N.; Powderly, J. D.; Topalian, S. L.; Zhao, H.; Waxman, I. M.; Hammers, H. J. |
| Abstract Title: | Long-term overall survival (OS) with nivolumab in previously treated patients with advanced renal cell carcinoma (aRCC) from phase I and II studies |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 245s |
| Language: | English |
| ACCESSION: | WOS:000404665407080 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4507 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4507 -- Source: Wos |
